Petefészekrák: vizsgálatok itt: Oroszország
2 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Where
- Omsk, Saint Petersburg
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00 - 2. fázisTaking peopleIntensification Treatment of Ovarian Cancer by PIPAC
- Where
- Balashikha
- Életkor
- 18 év to 75 év
- People
- 160
- Run by
- Moscow Regional Oncological Dispensary
See details and how to joinNCT07514494